Separation methods for catechol O-methyltransferase activity assay: Physiological and pathophysiological relevance

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 781, Issue 1-2, 2002, Pages 359-372

  Pihlavisto, P ^a,b   Reenila, I ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b ORION CORPORATION   (Finland)

Author keywords

Catechol O methyltransferase; Enzymes; Reviews

Indexed keywords

BIOASSAY; ENZYME INHIBITION; MAGNESIUM PRINTING PLATES; PATHOLOGY; SUBSTRATES;

INCUBATION;

PHYSIOLOGY;

CATECHOL; CATECHOL METHYLTRANSFERASE; ENZYME INHIBITOR; MAGNESIUM; METHYL GROUP; NITECAPONE; S ADENOSYLMETHIONINE; TACAPONE; TOLCAPONE; UNCLASSIFIED DRUG;

ACCURACY; CALIBRATION; CATALYSIS; DRUG DETERMINATION; ELECTROCHEMISTRY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; ENZYME KINETICS; ENZYME SUBSTRATE; FLUORESCENCE; FLUOROMETRY; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INCUBATION TIME; INTERMETHOD COMPARISON; LIQUID LIQUID EXTRACTION; METHYLATION; NONHUMAN; PAPER CHROMATOGRAPHY; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOCHEMISTRY; RELIABILITY; REVIEW; SENSITIVITY ANALYSIS; SEPARATION TECHNIQUE; THIN LAYER CHROMATOGRAPHY; ULTRAVIOLET SPECTROSCOPY; VALIDATION PROCESS; ISOLATION AND PURIFICATION; KINETICS; METABOLISM; PHYSIOLOGY;

CATALYSIS; CATECHOL O-METHYLTRANSFERASE; KINETICS;

EID: 0037027860     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1570-0232(02)00429-4     Document Type: Review

References (121)

1. Axelrod J., Tomchick R.J. J. Biol. Chem. 233:1958;702.
2. Guldberg H., Marsden C. Pharmacol. Rev. 27:1975;135.
3. Männistö P.T., Ulmanen I., Lundström K., Taskinen J., Tenhunen J., Tilgmann C., Kaakkola S. Progress in Drug Research. 1992;291 Birkhäuser Verlag, Basel, Switzerland.
4. Tilgmann C., Kalkkinen N. FEBS Lett. 264:1990;95.
5. Tilgmann C., Kalkkinen N. Biochem. Biophys. Res. Commun. 174:1991;995.
6. Salminen M., Lundström K., Tilgmann C., Savolainen R., Kalkkinen N., Ulmanen I. Gene. 93:1990;241.
7. Lundström K., Salminen M., Jalanko A., Savolainen R., Ulmanen I. DNA Cell Biol. 10:1991;181.
8. Bertocci B., Miggiano V., Da Prada M., Dembic Z., Lahm H.-W., Malherbe P. Proc. Natl. Acad. Sci. USA. 88:1991;1416.
9. Malherbe P., Bertocci B., Caspers P., Zürcher G., Da Prada M. J. Neurochem. 58:1992;1782.
10. Lundström K., Tilgmann C., Peränen J., Kalkkinen N., Ulmanen I. Biochim. Biophys. Acta. 1129:1992;149.
11. Tilgmann C., Melén K., Lundström K., Jalanko A., Julkunen I., Kalkkinen N., Ulmanen I. Eur. J. Biochem. 207:1992;813.
12. Ulmanen I., Peränen J., Tenhunen J., Tilgmann C., Karhunen T., Panula P., Bernasconi L., Aubry J.-P., Lundström K. Eur. J. Biochem. 243:1997;452.
13. Lotta T., Vidgren J., Tilgmann C., Ulmanen I., Melén K., Julkunen I., Taskinen J. Biochemistry. 34:1995;4202.
14. Nissinen E. Biochem. Pharmacol. 33:1984;3105.
15. Weisz J., Fritz-Wolz G., Clawson G.A., Benedict C.M., Abenroth C., Creveling C. Carcinogenesis. 19:1998;1307.
16. Tenhunen J., Salminen M., Lundström K., Kiviluoto T., Savolainen R., Ulmanen I. Eur. J. Biochem. 223:1994;1049.
17. Eisenhofer G., Keiser H., Friberg P., Mezey E., Huynh T.-T., Hiremagalur B., Elllingson T., Duddempudi S., Eijsbouts A., Lenders J.W.M. J. Clin. Enocrinol. Metab. 83:1998;2175.
18. Ulmanen I., Lundström K. Eur. J. Biochem. 243:1991;1013.
19. Karhunen T., Tilgmann C., Ulmanen I., Panula P. Neurosci. Lett. 187:1995;57.
20. Tenhunen J., Heikkilä P., Alanko A., Heinonen E., Akkila J., Ulmanen I. Cancer Lett. 144:1999;75.
21. Bonifati V., Meco G. Pharmacol. Ther. 81:1999;1.
22. Rivera-Calimlim L., Reilly D.K. Clin. Pharmacol. Ther. 35:1984;804.
23. McLeod H.L., Fang L., Luo X., Scott E.P., Evans W.E. J. Pharmacol. Exp. Ther. 270:1994;26.
24. Männistö P.T., Kaakkola S. Pharmacol. Rev. 51:1999;593.
25. Axelrod J., Cohn C.K. J. Pharmacol. Exp. Ther. 176:1971;650.
26. Poitou P., Assicot M., Bohuon C. Biomedicine. 21:1974;91.
27. Sladek-Chelgren S., Weinshilboum R. Biochem. Genet. 19:1981;1037.
28. Roth J.A. Rev. Physiol. Biochem. Pharmacol. 120:1992;1.
29. Boudikova B., Szumlanski C., Maidak B., Weinshilboum R. Clin. Pharmacol. Ther. 282:1990;812.
30. Grossman M.H., Emanuel B.S., Budarf M.L. Genomics. 12:1992;822.
31. Weinshilboum R.M. Clin. Biochem. 21:1988;201.
32. Lachman H.M., Papolos D.F., Saito T., Yu Y.-M., Szumlanski C.L., Weinshilboum R.M. Pharmacogenetics. 6:1996;243.
33. Dawling S., Roodi N., Mernaugh L., Wang X., Parl F.F. Cancer Res. 61:2001;6716.
34. Lavigne J.A., Helzlsouer K.J., Huang H.-Y., Strickland P.T., Bell D.A., Selmin O., Watson M.A., Hoffman S., Comstock G.W., Yager J.D. Cancer Res. 57:1997;5493.
35. Tiihonen J., Hallikainen T., Lachman H., Saito T., Volovka J., Kauhanen J., Salonen J.T., Ryynänen O.-P., Koulu M., Karvonen M.K., Pohjalainen T., Syvälahti E., Hietala J. Mol. Psychiatry. 4:1999;286.
36. Weinshilboum R.M., Raymond F.A., Frohnauer M. Biochem. Pharmacol. 28:1979;1239.
37. Feldman J.M., Reintgen D.S., Seigler H.F. Diabetologia. 17:1979;249.
38. Cavalieri E.L., Stack D.E., Devanesan P.D., Todorovic R., Dwivey I., Higginbotham S., Johansson S.L., Patil K.D., Gross M.L., Gooden J.K., Ramanathan R., Cerny R.L., Rogan E.G. Proc. Acad. Natl. Sci. 94:1997;10937.
39. Zhu B.T., Conney A.H. Carcinogenesis. 19:1998;1.
40. Xie T., Ho S.-L., Ramsden D. Mol. Pharmacol. 56:1999;31.
41. Rivett J., Francis A., Roth J.A. J. Neurochem. 40:1983;215.
42. Kaakkola S., Männistö P.T., Nissinen E. J. Neural. Transm. Gen. Sec. 60:1987;221.
43. Reenilä I., Tuomainen P., Soinila S., Männistö P.T. Neurosci. Lett. 230:1997;155.
44. Vidgren J., Ovaska M. Veerapandian P., Structure-based Drug Design. 1997;343 Marcel Dekker, New York.
45. Weinshilboum R.M., Raymond F.A. Biochem. Pharmacol. 25:1976;573.
46. Raymond F.A., Weinshilboum R.M. Clin. Chim. Acta. 58:1975;185.
47. Shultz E., Nissinen E., Kaakkola S. Biomed. Chromatogr. 3:1989;64.
48. Jeffery D.R., Roth J. J. Neurochem. 33:1984;3105.
49. Coward J.K., Slisz E.P., Wu F.Y.-H. Biochemistry. 12:1973;2291.
50. Coward J.K., Wu F.Y.-H. Anal. Biochem. 55:1973;406.
51. Gulliver P.A., Tipton K.F. Biochem. Pharmacol. 27:1978;773.
52. Zürcher G., Da Prada M. J. Neurochem. 38:1982;191.
53. Ball P., Knuppen R., Haupt M., Breuer H. Eur. J. Biochem. 26:1972;560.
54. Creveling C.R., McNeal E.T., Cantacuezene D., Kirk K.L. J. Med. Chem. 24:1981;1395.
55. Thakker D.R., Boehlert C., Kirk K.L., Antkowiak R., Creveling C.R. J. Biol. Chem. 261:1986;178.
56. Creveling C.R., Morris N., Shimizu H., Ong H.H., Daly J. Mol. Pharmacol. 8:1972;398.
57. Lautala P., Ulmanen I., Taskinen J. J. Chromatogr. B. 736:1999;143.
58. Kern C., Bernards C.M. Anesthesiology. 86:1997;405.
59. Koh S., Urayama K., Kawai S., Takayama Y. J. Chromatogr. 549:1991;434.
60. Rivett J., Eddy B., Roth J.A. J. Neurochem. 39:1982;1009.
61. Nakahara D., Ozaki N., Nagatsu T. Parvez S.H., Naoi M., Nagatsu T., Parvez S., Methods in Neurotransmitter and Neuropeptide Research. 1993;219 Elsevier, Amsterdam. Chapter 7.
62. Rivett A.J., Roth J.A. Biochemistry. 21:1982;1740.
63. Reenilä I., Männistö P.T. Med. Hypothesis. 57:2001;628.
64. Ball P., Knuppen R., Haupt M., Breuer H. J. Clin. Endocrinol. Metab. 34:1972;736.
65. Creveling C., Dalgard N., Shimizu N., Daly J. Mol. Pharmacol. 6:1970;691.
66. Allen E., Myers C., Frank D., Pettigrew A., Thompson S., Blumer J.L. J. Chromatogr. B. 578:1992;175.
67. Reenilä I., Tuomainen P., Tilgmann C., Männistö P.T. Pharmacol. Toxicol. 77:1995;414.
68. Ellingson T., Duddempudi S., Greenberg B.D., Hooper D., Eisenhofer G. J. Chromatogr. B. 729:1999;347.
69. Tuomainen P., Reenilä I., Männistö P.T. J. Pharm. Biomed. Anal. 14:1996;515.
70. Tilgmann C., Ulmanen I. J. Chromatogr. B. 684:1996;147.
71. Shultz E., Nissinen E. Biochem. Pharmacol. 38:1989;3953.
72. Borges N., Vieria-Coelho M.A., Parada A., Soares-da Silva P. J. Pharmacol. Exp. Ther. 282:1997;812.
73. Vieira-Coelho M.A., Soares-da-Silva P. Brain Res. 821:1999;69.
74. Reenilä I., Tuomainen P., Soinila S., Tuominen R.K., Männistö P.T. Neurosci. Res. Commun. 25:1999;71.
75. Vieira-Coelho M.A., Soares-da-Silva P. Br. J. Pharmacol. 117:1996;516.
76. Wilson W.G., Groohman M., Trendeleburg U. Naunyn-Schmiedeberg's Arch. Pharmacol. 337:1988;397.
77. Guimaraes S., Trendelenburg U. Trends Pharmacol. Sci. 6:1985;371.
78. Trenedelenburg U. Naunyn-Schmiedeberg's Arch. Pharmacol. 332:1986;201.
79. Trendelenburg U. J. Neural. Transm. Suppl. 32:1990;3.
80. Bryan-Lluka L.J. Naunyn-Schmiedeberg's Arch. Pharmacol. 351:1994;408.
81. Abdel-Latif A.A. Anal. Biochem. 29:1969;468.
82. Herblin W.F. Anal. Biochem. 51:1973;19.
83. Borchardt R.T. Anal. Biochem. 58:1974;382.
84. Axelrod J., Cohn C.K. J. Pharmacol. Exp. Ther. 176:1971;650.
85. Reilly D.K., Rivera-Calimlim L., Van Dyke D. Clin. Pharmacol. Ther. 28:1980;278.
86. Axelrod J., Albers W., Clemente C.D. J. Neurochem. 5:1959;68.
87. Griffits J., Linklater H. Clin. Chim. Acta. 39:1972;383.
88. Nikodejevic B., Senoh S., Daly J.W., Creveling C.R. J. Pharmacol. Exp. Ther. 174:1970;83.
89. McCaman R.E. Life Sci. 4:1965;2353.
90. Assicot M., Bohuon C. Nature. 212:1966;861.
91. Broch O.J., Guldberg H.C. Acta Pharmacol. Toxicol. 30:1971;266.
92. Jonas W.Z., Gershon E.S. Clin. Chim. Acta. 54:1974;391.
93. Huh M.M., Friedhoff A.J. J. Biol. Chem. 254:1979;299.
94. Bates G.W., Edman C.D., Porter J.C., Johnston J.M., MacDonald P.C. Clin. Chim. Acta. 94:1979;63.
95. Ball P., Knuppen R., Breuer H. Eur. J. Biochem. 21:1971;517.
96. Lin R.-L., Narasimhachari N. Anal. Biochem. 57:1974;46.
97. Zaitsu K., Okada Y., Nohta H., Kohashi K., Ohkura Y. J. Chromatogr. 211:1981;129.
98. Nohta H., Noma S., Ohkura Y., Yoo B.T. J. Chromatogr. 308:1984;93.
99. Mitamura K., Yatera M., Shimada K. J. Chromatogr. B. 748:2000;89.
100. Maurer H.H., Bickeboeller-Friedrich J., Kraemer T. J. Chromatogr. B. 739:2000;325.
101. Scanlon P.D., Raymond F.A., Weinshilboum R.M. Science. 203:1979;63.
102. Klemetsdal B., Straume B., Giverhaug T., Aarbakke J. Eur. J. Clin. Pharmacol. 46:1994;231.
103. Zürcher G., Da Prada M., Dingemanse J. Biomed. Chromatogr. 10:1996;32.
104. Reenilä I., Tuomainen P., Männistö P.T. J. Chromatogr. B. 663:1995;137.
105. Borchardt R.T., Hegazi M.F., Schowen R.L. J. Chromatogr. 152:1978;255.
106. Pennings J.M., Van Kempen G.M.J. Anal. Biochem. 98:1979;452.
107. Brevitt S.E., Tan E.W. J. Med. Chem. 40:1997;2035.
108. Schüsler-van Hees M.T.I.W., Beijersbergen van Henegouwen G.M.J. J. Chromatogr. 196:1980;101.
109. Smit N.P.M., Pavel S., Kammeyer A., Westerhof W. Anal. Biochem. 190:1990;286.
110. Dingemanse J., Jorga K., Zürcher G., Schmitt M., Sedek G., Da Prada M., Van Brummelen P. Br. J. Clin. Pharmacol. 40:1995;253.
111. Jorga K., Fotteler B., Schmitt M., Nielsen T., Zürcher G., Aitken J. Eur. Neurol. 38:1997;59.
112. Jorga K.M., Fotteler B., Heizmann P., Zürcher G. Eur. J. Clin. Pharmacol. 54:1998;443.
113. Nissinen E. Anal. Biochem. 144:1985;247.
114. Lautala P., Ulmanen I., Taskinen J. Mol. Pharmacol. 59:2001;393.
115. Koh S., Arai M., Kawai S., Okamoto M. J. Chromatogr. 226:1981;461.
116. Ishimitsu T., Hirose S. Anal. Biochem. 150:1985;300.
117. Nissinen E., Männistö P.T. Anal. Biochem. 137:1984;69.
118. Keränen T., Gordin A., Karlsson M., Korpela K., Pentikäinen P.J., Rita H., Schultz E., Seppälä L., Wikberg T. Eur. J. Clin. Pharmacol. 46:1994;151.
119. Kaakkola S., Gordin A., Järvinen M., Wikberg T., Schultz E., Nissinen E., Pentikäinen P.J., Rita H. Clin. Neuropharmacol. 13:1990;436.
120. Tsunoda M., Takezawa K., Imai K. Analyst. 126:2001;637.
121. Bergquist J., Sciubisz A., Kaczor A., Silberring J. J. Neurosci. Methods. 113:2002;1.